Stemtech Corporation Announces Leading Clinical Physician to Research the Values of Stemtech RCM Products
Stemtech Corporation, the global leader and pioneer in stem cell nutrition, is proud to announce the collaboration with Dr. Sabine Hazan, MD., whose medical pedigree includes specializing in gastroenterology, hepatology, internal medicine and natural remedies.
She has conducted over 300 clinical trials as part of her research efforts. Her pioneering work during Covid-19, where she clarified her patented protocol for hydroxychloroquine, Z-pack, Vitamin C, D and Zinc, was strategically posted to ‘sound the alarm’ and inform the world and similarly for a subsequent ivermectin, doxycycline, and zinc protocol.
This joint effort of two pioneer thought leaders with Dr. Hazan and Stemtech is expected to be an exceptional step forward to benefit health and wellness.
With growing awareness of the health benefits of adult stem cells, Dr. Hazan and Stemtech Corporation are working together with a plan to conduct clinical trials on Stemtech’s RCM System (R – Stemrelease3™ – release), (C – StemFlo Advanced® – circulation) and (M – MigraStem® – migration) patented nutraceutical products.
Stemtech products are the pioneer of all-natural, plant-based stem cell nutrition products since 2005 and have cumulative sales of over $600 million USD, with returns of less than 2 percent. Stemtech currently distributes their products in the United States, Mexico, Ecuador, Canada and Taiwan.
John W. Meyer, President & COO of Stemtech commented:
“This collaboration with Dr. Hazan is very beneficial as a milestone not only for our Company, but also as a critical contribution to the health and wellness of people around the world. Dr. Hazan’s indication is that the natural, plant-based approach of the RCM system and its potential for inflammation management.
Dr. Hazan’s intention is to conduct transparent, data-driven clinical trials, with a commitment to reporting both positive and negative outcomes to enhancing anti-aging as well as the benefits of a person’s own DNA stem cells healing the human body.”
The main focus of this project will be to evaluate the effect of Stemtech’s products on the microbiome.
Stemtech Chairman & CEO Charles S. Arnold shared:
“Dr. Hazan’s history of credible research and experience will be invaluable to the future development of additional products from the natural stem cell genre and other leading-edge health and wellness offerings.”
Dr. Hazan is credited for addressing issues like “leaky gut” and “irritable bowel syndrome” (IBS) and is a world Key Opinion leader in the subject. Dr. Hazan’s transition from pharmaceutical to natural healing pathways, emphasizing the credibility and scientific rigor behind this initiative, depicts her vast knowledge of medicine and natural plant remedies.
Dr. Hazan states:
“We can enable expansion of other products, not only Stemtech’s ‘stemceutical™’ natural health improvements, but also the development of broader research with greater benefits that have not yet been identified.
This would include development of microbiome health, aligning with the concept of precision medicine where individuals test their personal microbiome rather than just taking prescribed pills.
In this collaboration we will be developing detailed clinical trial protocols – including patient procurement strategies, defined endpoints.
It will be worthwhile to conduct clinical trials to document the benefits the products have on users. I am excited to be working with Stemtech to add my experience as part of their longevity and wellness program.”
Get more information, facts and figures about Stemtech, click here for the Stemtech overview.
Disclaimer: At BFH, we strive to keep all content—articles, press releases, data—as accurate and current as possible. However, treat this content as a guide, not as definitive authority for business decisions. Publishing a press release does not imply Business For Home BV endorses a company or individual, nor guarantees its claims. No warranties or representations, expressed or implied, are made regarding the accuracy, completeness, or suitability of information provided on this website. All content is provided “as-is,” without liability for errors or usage. Always fact-check and conduct your own due diligence. BFH publishes press releases for the global Direct Selling / Network Marketing / Home Business community. Laws governing Direct Selling can vary greatly by country; BFH does not warrant that any company or content is in full compliance with various local or country-specific laws; it’s up to the reader to research, verify and comply with all applicable local regulations.
Recommended Distributors Stemtech
Mike and Margie Mares
